What aspect does the Biosafety Protocol specifically address?

The correct response emphasizes the focus of the Biosafety Protocol, which specifically addresses the international movement of living modified organisms (LMOs). This protocol, part of the Cartagena Protocol on Biosafety established under the Convention on Biological Diversity, was created to ensure that countries have the tools to assess and manage the potential risks associated with LMOs, especially when they are transboundary.

Essentially, the Biosafety Protocol provides a regulatory framework for the safe transport, handling, and use of these organisms, ensuring that biodiversity is protected while also allowing for advancements in biotechnology. It aims to promote informed decision-making at the national level and encourages the sharing of information among countries regarding the impacts of LMOs on human health and the environment.

This specificity makes it clear that the other options, such as promoting organic farming, addressing financial aspects of biotechnology, or training agricultural workers, are not the primary focus of the Biosafety Protocol. Instead, these aspects may be relevant to broader agricultural policies or biotechnology initiatives, but they do not pertain directly to the concerns related to the safe movement of living modified organisms outlined in the Protocol.